<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04001855</url>
  </required_header>
  <id_info>
    <org_study_id>1906687954</org_study_id>
    <nct_id>NCT04001855</nct_id>
  </id_info>
  <brief_title>Evaluating the Effect of Bathing Additives in Atopic Dermatitis</brief_title>
  <official_title>Evaluating the Effect of Bathing Additives in Atopic Dermatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arizona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Arizona</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This proposed project will be an open-label, split-arm, randomized controlled pilot study. Up
      to 60 patients diagnosed with atopic dermatitis (eczema) will be enrolled in the study. The
      purpose of this study is to understand the change in skin barrier function and skin microbial
      composition in patients with atopic dermatitis following dilute bleach bath/soak and dilute
      vinegar bath/soak.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Atopic dermatitis (AD), also known as eczema, is an inflammatory skin condition that affects
      children and adults and causes skin redness, dryness and itching. Dilute bleach baths are
      standard of care for treatment of AD and work to decrease skin inflammation and modulate the
      skin microbiome. Dilute vinegar (acetic acid) has been reported to have similar effects on
      the skin. The purpose of this study is to evaluate the change in skin barrier function and
      skin microbial composition following baths or gauze soaks with dilute bleach and dilute
      vinegar.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2019</start_date>
  <completion_date type="Anticipated">July 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized control split body study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Skin barrier function - Transepidermal water loss (TEWL)</measure>
    <time_frame>Up to 21 days</time_frame>
    <description>Assess skin barrier function through measurement of transepidermal water loss (in g/m^2h) using a commercially-available, non-invasive device (Delfin VapoMeter: http://www.delfintech.com/en/product_information/vapometer/).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Skin barrier function - Stratum corneum hydration</measure>
    <time_frame>Up to 21 days</time_frame>
    <description>Assess skin barrier function through measurement of stratum corneum hydration (in arbitrary units) using a commercially-available, non-invasive device (Delfin MoistureMeterSC: http://www.delfintech.com/en/product_information/moisturemetersc/).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Skin barrier function - pH</measure>
    <time_frame>Up to 21 days</time_frame>
    <description>Assess skin barrier function through measurement of stratum corneum pH (in pH units) using a commercially-available, non-invasive device.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Skin culture swab</measure>
    <time_frame>Up to 21 days</time_frame>
    <description>Assess microbial composition via collection of non-invasive, non-painful skin culture swab samples.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Eczema Area and Severity Index (EASI)</measure>
    <time_frame>Up to 21 days.</time_frame>
    <description>Clinical grading of atopic dermatitis/eczema severity (higher EASI scores indicating more severe AD).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Atopic Dermatitis</condition>
  <condition>Eczema</condition>
  <arm_group>
    <arm_group_label>Dilute vinegar vs. dilute bleach bath</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will complete a total of 5 study visits over 11 days. At visits 1-4, subjects will soak their forearms in either dilute bleach or dilute vinegar for 10 minutes. At all visits, measurements of skin barrier function will be obtained using non-invasive, commercially-available devices. Non-invasive, non-painful tape stripping samples and skin culture swabs will also be collected.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dilute vinegar vs. dilute bleach gauze soaks</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will complete a total of two study visits over 21 days, and will be instructed to apply gauze soaks daily at home over the 21-day study period. At baseline and 21-day follow-up visits, measurements of skin barrier function will be obtained using non-invasive, commercially-available devices. Non-invasive, non-painful tape stripping samples and skin culture swabs will also be collected. Subjects will also be provided with a non-invasive skin barrier measurement device to take daily recordings at home.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dilute vinegar (acetic acid)</intervention_name>
    <description>Dilute vinegar baths or gauze soaks</description>
    <arm_group_label>Dilute vinegar vs. dilute bleach bath</arm_group_label>
    <arm_group_label>Dilute vinegar vs. dilute bleach gauze soaks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dilute bleach</intervention_name>
    <description>Dilute bleach baths or gauze soaks</description>
    <arm_group_label>Dilute vinegar vs. dilute bleach bath</arm_group_label>
    <arm_group_label>Dilute vinegar vs. dilute bleach gauze soaks</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females, at least 5 years of age

          -  Subjects, parents/legal guardians must be able to comprehend and read the English
             language

          -  Subjects must have a diagnosis of atopic dermatitis (AD) by a board-certified
             dermatologist

        Exclusion Criteria:

          -  Subjects who do not fit the inclusion criteria

          -  Subjects unable or unwilling to comply with the study procedures

          -  Concurrently have other inflammatory skin conditions

          -  Prior known allergies to any components of the materials used

          -  A subject who in the opinion of the investigator will be uncooperative or unable to
             comply with study procedures

          -  Subject unable to speak or read the English language

          -  Those that are pregnant, prisoners or cognitively impaired
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>UA Dermatology Clinical Trials Unit</last_name>
    <phone>520-694-1828</phone>
    <email>uadermatologyresearch@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Banner University Medicine Dermatology</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85718</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>UA Dermatology Clinical Trials Unit</last_name>
      <phone>520-694-1828</phone>
      <email>uadermatologyresearch@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Vivian Y Shi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 25, 2019</study_first_submitted>
  <study_first_submitted_qc>June 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 28, 2019</study_first_posted>
  <last_update_submitted>June 26, 2019</last_update_submitted>
  <last_update_submitted_qc>June 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Atopic Dermatitis</keyword>
  <keyword>Eczema</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatitis, Atopic</mesh_term>
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Eczema</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetic Acid</mesh_term>
    <mesh_term>Retinol acetate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

